|
⚲
|
| Keyboard |
| Jhaveri Nirav S
✚
|
|
|---|---|
| CIK # | 0002011481 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002011481] | |
| 4 | [0002011481] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rexahn Pharmaceuticals Inc | |
| Jhaveri Nirav S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2025-03-13 | Grant | 52,500 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Employee Stock Option (right to buy) · derivative
|
2025-03-13 | Grant | 52,500 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2025-02-13 | Tax withheld | 8,207 | $1.15 | 9,438 |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-03-21 | Buy | 10,000 | $2.10 | 21,000 |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-02-12 | Grant | 140,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Employee Stock Option (right to buy) · derivative
|
2024-02-12 | Grant | 210,000 | $0.00 |